← Back to Clinical Trials
Recruiting NCT06490783

NCT06490783 Cyber-Human Systems for Personalized Well-being and Health

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06490783
Status Recruiting
Phase
Sponsor Istituto per la Ricerca e l'Innovazione Biomedica
Condition Geriatric Health Services
Study Type OBSERVATIONAL
Enrollment 10 participants
Start Date 2024-07-01
Primary Completion 2025-12-31

Eligibility & Interventions

Sex All sexes
Min Age 60 Years
Max Age N/A
Study Type OBSERVATIONAL
Interventions
Noninvasive wearable devices (smartwatch and heart rate monitor band)

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 10 participants in total. It began in 2024-07-01 with a primary completion date of 2025-12-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The purpose of the present study is to evaluate the effectiveness of using multi-parameter monitoring devices in the elderly to improve their quality of life not already understood as the absence of disease but in a logic that is intrinsically linked to the body-mind relationship, which is increasingly significant as biological age advances. The study will be conducted on a sample of volunteer elderly subjects who will wear devices capable of constantly monitoring vital parameters such as heart rate, physical activity, sleep quality, stress levels and higher level activities, linked sensory and cognitive aspects ecologically integrated with the elderly person's living environment, in the sense of an evaluative and qualitative focus on relationships within the person's area of action/interaction, possibly supported and stimulated by individualized and easily usable activities. The signals interpreted and returned by the technology to the elderly person who uses it can also act as a reassuring self-assessment of even normal body states, sometimes experienced as threatening and anxiogenic, thus stressful. The collection and management of these data may serve as a reference to the recognition of distress signals and complex experiences (e.g., depressive) that normally have significant effects on mental health, understood as intrinsically linked to the health of the body.

Eligibility Criteria

Inclusion Criteria: * healthy male and female aged 60 years and older * signing of informed consent Exclusion Criteria: * chronic diseases * cardiovascular disease * presence of dementia and/or depression * presence of confirmed paranoid or psychotic symptoms

Contact & Investigator

Central Contact

Gennaro Tartarisco

✉ gennaro.tartarisco@irib.cnr.it

📞 +393283377046

Principal Investigator

Gennaro Tartarisco

PRINCIPAL INVESTIGATOR

Istituto per la Ricerca e l'Innovazione Biomedica

Frequently Asked Questions

Who can join the NCT06490783 clinical trial?

This trial is open to participants of all sexes, aged 60 Years or older, studying Geriatric Health Services. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06490783 currently recruiting?

Yes, NCT06490783 is actively recruiting participants. Contact the research team at gennaro.tartarisco@irib.cnr.it for enrollment information.

Where is the NCT06490783 trial being conducted?

This trial is being conducted at Messina, Italy.

Who is sponsoring the NCT06490783 clinical trial?

NCT06490783 is sponsored by Istituto per la Ricerca e l'Innovazione Biomedica. The principal investigator is Gennaro Tartarisco at Istituto per la Ricerca e l'Innovazione Biomedica. The trial plans to enroll 10 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology